Phospholipase A2 and spinal cord injury: a novel target for therapeutic intervention.
Andrea D
AD
Olivas
Linda J
LJ
Noble-Haeusslein
D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology; D008775:Methylprednisolone / Q000627:therapeutic use; D008954:Models, Biological; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018384:Oxidative Stress / Q000187:drug effects; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000378:metabolism*; D054467:Phospholipases A2; D017382:Reactive Oxygen Species / Q000378:metabolism; D013119:Spinal Cord Injuries / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology*
D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species; D010741:Phospholipases A; D054467:Phospholipases A2; D008775:Methylprednisolone